Concord Drugs Share Price

BSE
CONCORD •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Concord Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
40.05% Fall from 52W High
-5.6
TTM PE Ratio
High in industry
4042.8
Price to Book Ratio
Low in industry
1.1
Dividend yield 1yr %
0
TTM PEG Ratio

Concord Drugs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Jun 2024 - 11.69287 Cr Mar 2024 - 44.93378 Cr
Mar 2024 - 15.64242 Cr Mar 2023 - 52.0895 Cr
Dec 2023 - 12.78375 Cr - Cr
Sep 2023 - 7.5167 Cr - Cr
Jun 2023 - 8.9816 Cr - Cr
Net Profit/Loss
QuarterlyYearly
Jun 2024 - 0.02732 Cr Mar 2024 - 0.47239 Cr
Mar 2024 - -0.33881 Cr Mar 2023 - 0.9855 Cr
Dec 2023 - -0.24119 Cr - Cr
Sep 2023 - 0.5618 Cr - Cr
Jun 2023 - 0.4906 Cr - Cr

Concord Drugs Ltd shareholding Pattern

Promoter
55.4%
Public
44.6%
Promoter
55.4%
Public
44.6%
Promoter
55.4%
Public
44.6%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%

Concord Drugs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5Day EMA
37.70
10Day EMA
37.60
12Day EMA
37.50
20Day EMA
37.20
26Day EMA
37.10
50Day EMA
37.20
100Day EMA
37.60
200Day EMA
37.50
5Day SMA
37.70
10Day SMA
37.80
20Day SMA
37.10
30Day SMA
36.20
50Day SMA
37.20
100Day SMA
37.70
150Day SMA
37.90
200Day SMA
39.50
Delivery & Volume
Day
Combined Delivery Volume- 6377 Rs
NSE+BSE Traded Volume- 7461 Rs

Week
Combined Delivery Volume- 5555 Rs
NSE+BSE Traded Volume- 7604 Rs

Month
Combined Delivery Volume- 10287 Rs
NSE+BSE Traded Volume- 13334 Rs

Resistance & Support
37.73
Pivot
Resistance
First Resistance
38.56
Second Resistance
39.22
Third Resistance
40.05
Support
First Support
37.07
Second support
36.24
Third Support
35.58
Relative Strength Index
57.13
Money Flow Index
71.92
MACD
0.37
MACD Signal
0.24
Average True Range
1.91
Average Directional Index
15.40
Rate of Change (21)
16.37
Rate of Change (125)
5.40

Concord Drugs Ltd Company background

Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Read More

Concord Drugs Ltd FAQs

You can easily buy Concord Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -